{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:24:03Z","timestamp":1790209443101,"version":"4.1.0"},"reference-count":18,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870905, U20A20358, 82111530203"],"award-info":[{"award-number":["81870905, U20A20358, 82111530203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2019-I2M-5-029"],"award-info":[{"award-number":["2019-I2M-5-029"]}]},{"name":"the National Science and Technology Major Project","award":["2017ZX09304018"],"award-info":[{"award-number":["2017ZX09304018"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2023,11,30]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The benefit of intravenous alteplase in acute ischaemic stroke (AIS) is time-dependent. Tenecteplase is non-inferior to alteplase among patients with AIS. We aimed to delineate the association of the stroke onset to treatment time (OTT) with tenecteplase compared with alteplase on therapeutic benefit and clinical risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a post hoc analysis of the Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-2 an open-label, randomised, controlled, non-inferior trial. A total of 1430 AIS within 4.5\u2009hours onset at 53 sites in China from 12 June 2021 to 29 May 2022 were randomly assigned (1:1) to receive either tenecteplase 0.25\u2009mg\/kg or alteplase 0.9\u2009mg\/kg. The primary efficacy outcome was the proportion of participants with a modified Rankin Scale score of 0\u20131 at 90 days. A post hoc subgroup analysis was conducted with the OTT divided into three intervals (0\u201390\u2009min, 91\u2013180\u2009min and 181\u2013270\u2009min). The primary safety outcome was symptomatic intracranial haemorrhage within 36 hours post-thrombolytic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Treatment was initiated within 270\u2009min of stroke onset in 1412 patients who were randomly allocated to either tenecteplase (n=707) or alteplase (n=705). The OR of primary efficacy outcome was similar as OTT increased (p=0.84). Adjusted odds of an excellent functional outcome were 0.99 (95% CI 0.37 to 2.67) for 0\u201390\u2009min, 1.23 (95% CI 0.88 to 1.71) for 91\u2013180\u2009min and 1.21 (95% CI 0.88 to 1.65) for 181\u2013270\u2009min. All were in favour of the tenecteplase group. Meta-analysis of 2949 patients yielded a pooled risk difference of 5.54 (95% CI \u22120.18 to 11.26; p=0.82) in favour of tenecteplase for more than 180\u2009min and 1.77 (95% CI \u22122.66 to 6.20; p=0.58) for 0\u2013180\u2009min.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In AIS patients who were treated with either tenecteplase or alteplase within 4.5\u2009hours onset, there was no difference observed in the efficacy and safety between the two groups at the three different OTT time intervals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/svn-2023-002694","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T12:20:22Z","timestamp":1706703622000},"page":"613-622","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct04797013","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-0365","authenticated-orcid":false,"given":"Shuya","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-3676","authenticated-orcid":false,"given":"Runqi","family":"Wangqin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University Medical Center, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3082-6789","authenticated-orcid":false,"given":"Yuesong","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-5444","authenticated-orcid":false,"given":"Aoming","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8591-4105","authenticated-orcid":false,"given":"Hao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H","family":"Schwamm","sequence":"additional","affiliation":[{"name":"Department of Neurology and Comprehensive Stroke Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3632-9433","authenticated-orcid":false,"given":"Bruce C V","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Medicine and Neurology, Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W","family":"Parsons","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liverpool Hospital, University of New South Wales South Western Sydney Clinical School, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziran","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Linyi People's Hospital, Linyi, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguo","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Linfen Central Hospital, Linfen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tengzhou Central People's Hospital, Tengzhou, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhui","family":"Li","sequence":"additional","affiliation":[{"name":"Central Hospital Affiliated to Shenyang Medical College, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, General Hospital of DaTong Coal Mine Group, Datong, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Petznick Stroke Center, Barrow Neurological Institute, Phoenix, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8345-5147","authenticated-orcid":false,"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6400-5474","authenticated-orcid":false,"given":"Huaguang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1353-2295","authenticated-orcid":false,"given":"Yunyun","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-2341","authenticated-orcid":false,"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Department of Clinical Trial Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"key":"2026081206052924000_9.6.613.1","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2017-000074"},{"key":"2026081206052924000_9.6.613.2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000211"},{"key":"2026081206052924000_9.6.613.3","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European stroke Organisation (ESO) guidelines on intravenous Thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur Stroke J"},{"key":"2026081206052924000_9.6.613.4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.medj.2022.09.005","article-title":"The promise of Tenecteplase in acute stroke: within reach or beyond approval","volume":"3","author":"Zachrison","year":"2022","journal-title":"Med"},{"key":"2026081206052924000_9.6.613.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01054-6"},{"key":"2026081206052924000_9.6.613.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02600-9"},{"key":"2026081206052924000_9.6.613.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15692-4"},{"key":"2026081206052924000_9.6.613.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60491-6"},{"key":"2026081206052924000_9.6.613.9","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.000995"},{"key":"2026081206052924000_9.6.613.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6959"},{"key":"2026081206052924000_9.6.613.11","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2021-001074"},{"key":"2026081206052924000_9.6.613.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804656"},{"key":"2026081206052924000_9.6.613.13","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.025080"},{"key":"2026081206052924000_9.6.613.14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.4506","article-title":"Off-label use of Tenecteplase for the treatment of acute ischemic stroke: A systematic review and meta-analysis","volume":"5","author":"Katsanos","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026081206052924000_9.6.613.15","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.120.030220"},{"key":"2026081206052924000_9.6.613.16","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.10.3032"},{"key":"2026081206052924000_9.6.613.17","doi-asserted-by":"crossref","unstructured":"Gu B , Piebalgs A , Huang Y , et al . Mathematical Modelling of intravenous Thrombolysis in acute ischaemic stroke: effects of dose regimens on levels of fibrinolytic proteins and clot lysis time. Pharmaceutics 2019;11. doi:10.3390\/pharmaceutics11030111","DOI":"10.3390\/pharmaceutics11030111"},{"key":"2026081206052924000_9.6.613.18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.13647"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2023-002694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:07:06Z","timestamp":1786540026000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2023-002694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12,30]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/svn-2023-002694"],"URL":"https:\/\/doi.org\/10.1136\/svn-2023-002694","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]}}}